Literature DB >> 11562768

Molecular and biomarker analyses of salivary duct carcinomas: comparison with mammary duct carcinoma.

M P Hoang1, D L Callender, J J Sola Gallego, Z Huang, N Sneige, M A Luna, J G Batsakis, A K El-Naggar.   

Abstract

Salivary duct carcinoma (SDC) is a rare high-grade aggressive neoplasm that manifests close histologic features with invasive ductal carcinoma of the breast (IDC). In contrast to SDC, extensive molecular studies have been performed on IDC and led to the identification of certain biological markers. To investigate the underlying molecular and biologic characteristics of SDC, we performed molecular analyses using microsatellite markers on chromosomal arms 6q, 16q, 17p, and 17q, DNA flow cytometry and immunohistochemical staining for androgen receptor (AR) and p53 expression on 28 examples of these tumors in comparison to 24 IDC cases. Our results show that generally similar allelic alterations, elevated p53 and androgen receptor expressions, and high frequency of DNA aneuploidy are manifested in both SDCs and IDCs. Differences at certain markers on 6q, 17p and 17q chromosomal loci, however, were observed between the two entities. Certain loci on 6q were more frequently altered in SDC than IDC which loci on chromosomes 17p and q arms were more seen in IDCs than SDCs. The majority of SDCs had high AR expression while most of IDCs were AR negative. Our study indicates that: i) SDC may share some genetic alterations with IDC, ii) high AR expression in SDC may play a role in tumor progression, and iii) p53 overexpression and DNA aneuploidy in both entities reflect their aggressive behavior.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11562768     DOI: 10.3892/ijo.19.4.865

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  12 in total

1.  Breast metastasis of salivary duct carcinoma in a patient: a case report.

Authors:  Shuangshuang Guo; Jun Yao
Journal:  Int J Clin Exp Med       Date:  2015-11-15

Review 2.  Salivary duct carcinoma: new developments--morphological variants including pure in situ high grade lesions; proposed molecular classification.

Authors:  Roderick H W Simpson
Journal:  Head Neck Pathol       Date:  2013-07-03

Review 3.  Genetic alterations in salivary gland cancers.

Authors:  Linda X Yin; Patrick K Ha
Journal:  Cancer       Date:  2016-02-29       Impact factor: 6.860

4.  Alterations associated with androgen receptor gene activation in salivary duct carcinoma of both sexes: potential therapeutic ramifications.

Authors:  Yoshitsugu Mitani; Pulivarthi H Rao; Sankar N Maity; Yu-Chen Lee; Renata Ferrarotto; Julian C Post; Lisa Licitra; Scott M Lippman; Merrill S Kies; Randal S Weber; Carlos Caulin; Sue-Hwa Lin; Adel K El-Naggar
Journal:  Clin Cancer Res       Date:  2014-10-14       Impact factor: 12.531

Review 5.  [Salivary duct carcinoma].

Authors:  D Hungermann; K Roeser; H Buerger; T Jäkel; T Löning; H Herbst
Journal:  Pathologe       Date:  2005-09       Impact factor: 1.011

6.  Carcinoma ex pleomorphic adenoma of the salivary gland: an immunohistochemical study.

Authors:  Saori Matsubayashi; Toshio Yoshihara
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-02-20       Impact factor: 2.503

7.  Clinicopathological significance of androgen receptor, HER2, Ki-67 and EGFR expressions in salivary duct carcinoma.

Authors:  Tatsuo Masubuchi; Yuichiro Tada; Shin-ichiro Maruya; Yoshiyuki Osamura; Shin-etsu Kamata; Kouki Miura; Chihiro Fushimi; Hideaki Takahashi; Daisuke Kawakita; Seiji Kishimoto; Toshitaka Nagao
Journal:  Int J Clin Oncol       Date:  2014-02-20       Impact factor: 3.402

8.  Gene expression screening of salivary gland neoplasms: molecular markers of potential histogenetic and clinical significance.

Authors:  Shin-Ichiro Maruya; Hyung-Woo Kim; Randal S Weber; Jack J Lee; Merril Kies; Mario A Luna; John G Batsakis; Adel K El-Naggar
Journal:  J Mol Diagn       Date:  2004-08       Impact factor: 5.568

9.  Novel therapeutic strategies for malignant salivary gland tumors: lessons learned from breast cancer.

Authors:  Ryuichi Murase; Tomoki Sumida; Akiko Ishikawa; Rumi Murase; Sean D McAllister; Hiroyuki Hamakawa; Pierre-Yves Desprez
Journal:  Int J Otolaryngol       Date:  2011-11-21

10.  Clinical Outcomes and Prognostic Factors for Salivary Duct Carcinoma: A Multi-Institutional Analysis of 141 Patients.

Authors:  Kuninori Otsuka; Yorihisa Imanishi; Yuichiro Tada; Daisuke Kawakita; Satoshi Kano; Kiyoaki Tsukahara; Akira Shimizu; Hiroyuki Ozawa; Kenji Okami; Akihiro Sakai; Yuichiro Sato; Yushi Ueki; Yukiko Sato; Toyoyuki Hanazawa; Hideaki Chazono; Kaoru Ogawa; Toshitaka Nagao
Journal:  Ann Surg Oncol       Date:  2016-01-20       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.